A Randomized, Double-Blind, Placebo-Controlled Study in Cat-Allergic Patients With Allergic Rhinitis Who Live With a Cat to Assess the Efficacy and Safety of Anti-Fel d 1 Antibodies During Natural Cat Exposure in the Home
Latest Information Update: 12 Jun 2024
At a glance
- Drugs REGN 1908-1909 (Primary)
- Indications Allergic asthma; Allergic conjunctivitis; Allergic rhinitis
- Focus Registrational; Therapeutic Use
- Sponsors Regeneron Pharmaceuticals
- 25 Jun 2023 Status changed from active, no longer recruiting to discontinued due to lack of efficacy.
- 11 May 2023 This trial has been completed in Germany and Poland (End Date: 24 Apr 2023) according to European Clinical Trials Database record.
- 18 Apr 2023 This trial has been discontinued in Germany, according to European Clinical Trials Database record.